Cargando…

Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial

BACKGROUND: Ultrasound-guided greater occipital nerve (GON) block has been frequently used to treat various types of headaches, and botulinum toxin has recently begun to be used in patients with headache. Our study presents the long-term effect of botulinum toxin on GON block using ultrasound in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Jae Hyung, Shim, Jae Hang, Yeom, Jong Hoon, Shin, Woo Jong, Cho, Sang Yun, Jeon, Woo Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Anesthesiologists 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781206/
https://www.ncbi.nlm.nih.gov/pubmed/31159537
http://dx.doi.org/10.4097/kja.19145
_version_ 1783457315597320192
author Ryu, Jae Hyung
Shim, Jae Hang
Yeom, Jong Hoon
Shin, Woo Jong
Cho, Sang Yun
Jeon, Woo Jae
author_facet Ryu, Jae Hyung
Shim, Jae Hang
Yeom, Jong Hoon
Shin, Woo Jong
Cho, Sang Yun
Jeon, Woo Jae
author_sort Ryu, Jae Hyung
collection PubMed
description BACKGROUND: Ultrasound-guided greater occipital nerve (GON) block has been frequently used to treat various types of headaches, and botulinum toxin has recently begun to be used in patients with headache. Our study presents the long-term effect of botulinum toxin on GON block using ultrasound in patients with chronic headache in occipital area. METHODS: Patients with occipital headache were divided into two groups (bupivacaine: BUP group [n = 27], botulinum toxin: BTX group [n = 27]), and ultrasound-guided GON block was performed at the C2 level. GON was detected with ultrasound and distance from GON to midline, from the skin surface to GON, and size of GON were measured in both groups. Visual analogue scale (VAS) scores and Likert scale were assessed at pretreatment and at 1, 4, 8, and 24 weeks after treatment in both groups. RESULTS: The distance from GON to midline was 18.9 ± 4.4 mm (right) and 17.3 ± 3.8 mm (left). The depth from the skin was 12.9 ± 1.5 mm (right) and 13.4 ± 1.6 mm (left). GON size was 3.1 mm on both sides. The VAS score and patient satisfaction score (Likert scale) in 4, 8, and 24 weeks after injection were superior for the BTX than the BUP group. CONCLUSIONS: Ultrasound-guided GON block using BTX is effective in reducing short-term and long-term pain in patients with chronic headache in the occipital area.
format Online
Article
Text
id pubmed-6781206
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Anesthesiologists
record_format MEDLINE/PubMed
spelling pubmed-67812062019-10-17 Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial Ryu, Jae Hyung Shim, Jae Hang Yeom, Jong Hoon Shin, Woo Jong Cho, Sang Yun Jeon, Woo Jae Korean J Anesthesiol Clinical Research Article BACKGROUND: Ultrasound-guided greater occipital nerve (GON) block has been frequently used to treat various types of headaches, and botulinum toxin has recently begun to be used in patients with headache. Our study presents the long-term effect of botulinum toxin on GON block using ultrasound in patients with chronic headache in occipital area. METHODS: Patients with occipital headache were divided into two groups (bupivacaine: BUP group [n = 27], botulinum toxin: BTX group [n = 27]), and ultrasound-guided GON block was performed at the C2 level. GON was detected with ultrasound and distance from GON to midline, from the skin surface to GON, and size of GON were measured in both groups. Visual analogue scale (VAS) scores and Likert scale were assessed at pretreatment and at 1, 4, 8, and 24 weeks after treatment in both groups. RESULTS: The distance from GON to midline was 18.9 ± 4.4 mm (right) and 17.3 ± 3.8 mm (left). The depth from the skin was 12.9 ± 1.5 mm (right) and 13.4 ± 1.6 mm (left). GON size was 3.1 mm on both sides. The VAS score and patient satisfaction score (Likert scale) in 4, 8, and 24 weeks after injection were superior for the BTX than the BUP group. CONCLUSIONS: Ultrasound-guided GON block using BTX is effective in reducing short-term and long-term pain in patients with chronic headache in the occipital area. Korean Society of Anesthesiologists 2019-10 2019-06-04 /pmc/articles/PMC6781206/ /pubmed/31159537 http://dx.doi.org/10.4097/kja.19145 Text en Copyright © The Korean Society of Anesthesiologists, 2019 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research Article
Ryu, Jae Hyung
Shim, Jae Hang
Yeom, Jong Hoon
Shin, Woo Jong
Cho, Sang Yun
Jeon, Woo Jae
Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title_full Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title_fullStr Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title_full_unstemmed Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title_short Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
title_sort ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781206/
https://www.ncbi.nlm.nih.gov/pubmed/31159537
http://dx.doi.org/10.4097/kja.19145
work_keys_str_mv AT ryujaehyung ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial
AT shimjaehang ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial
AT yeomjonghoon ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial
AT shinwoojong ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial
AT chosangyun ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial
AT jeonwoojae ultrasoundguidedgreateroccipitalnerveblockwithbotulinumtoxinforpatientswithchronicheadacheintheoccipitalareaarandomizedcontrolledtrial